Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases

Thorax

Volumn 60, Issue 11, 2005, Pages 962-966

  Teig, N ^a   Anders, A ^b   Schmidt, C ^a   Rieger, C ^a   Gatermann, S ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; STEROID;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CHILD; CHLAMYDOPHILA PNEUMONIAE; CHRONIC BRONCHITIS; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYCOPLASMA PNEUMONIAE; NASAL BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM CULTURE;

ADOLESCENT; ASTHMA; BRONCHITIS, CHRONIC; CASE-CONTROL STUDIES; CHILD; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; HUMANS; MYCOPLASMA PNEUMONIAE; NOSE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SPUTUM;

EID: 27744456511     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.041004     Document Type: Article

References (49)

1. Grayston JT. A new respiratory tract pathogen. Chlamydia pneumoniae, strain TWAR. J Infect Dis 1990;161:618-25.
2. Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasma. Microb Pathog 2000;29:301-9.
3. Heiskanen-Kosma T, Korppi M, Laurila A, et al. Chlamydia pneumoniae is an important cause of community acquired pneumonia in school-aged children: serological results of a prospective population-based study. Scand J Infect Dis 1999;31:255-9.
4. Volanen I, Vainionpaa R, Ilonen J, et al. A prospective study of Chlamydia pneumoniae antibodies in children between 7 months and 8 years of age. Scand J Infect Dis 2003;35:471-7.
5. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-6.
6. Esposito S, Droghetti R, Bosis S, et al. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr Pulmonol 2002;34:122-7.
7. Freymuth F, Vabret A, Brouard J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999;13:131-9.
8. Lieberman D, Lieberman D, Ben-Yaakov M, et al. Infectious etiologies in acute exacerbations of COPD. Diagn Microbiol Infect Dis 2001;40:95-102.
9. Boman J, Sonderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998;178:274-7.
10. Byrne GI, Quelette SP, Wang Z, et al. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of Hep-2 cell. Infect Immunol 2001;69:5423-9.
11. Saikku P, Laitinen K, Leionen M. Animal models for Chlamydia pneumoniae infection. Atherosclerosis 1998;140:S17-19.
12. Ten Brinke A, van Dissel JT, Sterk PJ, et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 2001;107:449-54.
13. Von HL, Vasankari T, Liippo K, et al. Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis 2002;34:22-7.
14. Von Hertzen L, Toryla M, Gimishanov A, et al. Asthma, atopy and Chlamydia pneumoniae in adults. Clin Exp Allergy 1999;29:522-8.
15. Gencay M, Rüdiger JJ, Tamm M, et al. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001;163:1097-100.
16. Hahn DL, Anttila T, Saikku P. Association of Chlamydia pneumoniae antibodies with recently symptomatic asthma. Epidemiol Infect 1996;117:513-7.
17. Von Hertzen L, Isoaho R, Leinonen M, et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 1996;25:658-64.
18. Von Hertzen L, Alakarppa H, Koskinen R, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997;118:155-64.
19. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002;288:2724-31.
20. Villareal C, Whittum-Hudson JA, Hudson AP. Persistent Chlamydia and chronic arthritis. Arthritis Res 2002;4:5-9.
21. Munger KL, Peeling RW, Hernan MA, et al. Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology 2003;14:141-7.
22. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148:727-32.
23. Mills GD, Lindeman JA, Fawcett JP, et al. Chlamydia pneumoniae serological status is not associated with asthma in children and young adults. Int J Epidemiol 2000;29:280-4.
24. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-9.
25. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001;33:492-503.
26. Kern DG, Neill MA, Schachter J. A seroepidemiological study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 1993;104:208-13.
27. Johnston SL. Is Chlamydia pneumoniae important in asthma? Am J Respir Crit Care Med 2001;164:513-4.
28. Hammerschlag MR. The intracellular life of chlamydiae. Semin Pediatr Infect Dis 2002;13:239-48.
29. Waring AL, Halse TA, Csiza CK, et al. Development of a genomics-based PCR-assay for detection of Mycoplasma pneumoniae in a large outbreak in New York City. J Clin Microbiol 2001;39:1385-90.
30. Tondella ML, Talkington DF, Holloway BP, et al. Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol 2002;40:575-83.
31. Martin RJ, Kraft M, Wei H, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107:595-601.
32. Schmidt SM, Muller CE, Bruns R, et al. Branchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children. Pediatr Allergy Immunol 2001;12:257-65.
33. Fong IW, Chiu B, Biira E, et al. Can an antibiotic (macrolide) prevent Chlamydia pneumoniae induced atherosclerosis in a rabbit model? Clin Diag Lab Immunol 1999;6:891-4.
34. Kips JC, Fahy JV, Hargreave FE, et al. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J 1998;11(Suppl):9-12s.
35. Bernet C, Garret M, de Barbeyrac B, et al. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol 1989;27:2492-6.
36. Abele-Horn M, Franck W, Busch U, et al. Transverse myelitis associated with Mycoplasma pneumoniae. Infection 1998;26:909-12.
37. Maass M, Krause E, Engel PM, et al. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 1997;48:699-706.
38. Campbell LA, Perez Melgosa M, Hamilton DJ, et al. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 1992;30:434-439.
39. Blasi F, Damato S, Consentini R, et al. Chlamydia pneumoniae and chronic bronchitis: association, severity and bacterial clearance following treatment. Chlamydia InterAction with COPD (CIAC) Study Group. Thorax 2002;57:672-6.
40. Miyashita N, Yoshishito N, Nakajima M, et al. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 2001;119:1416-9.
41. Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and children with respiratory tract infections. Pediatr Infect Dis J 1997;16:549-54.
42. Wu L, Skinner JM, Lambie N, et al. Immunohistochemical staining for chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1148-51.
43. Smieja M, Leigh R, Petrich A, et al. Smoking, season, and detection of chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis 2002;2:12.
44. Miyashita N, Kubota Y, Nakajima M, et al. Chlamydia pneumoniae and exacerbation of asthma in adults. Ann Allergy Asthma Immunol 1998;80:405-9.
45. Moazed TC, Kuo CC, Grayston JT, et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-5.
46. Biscione GL, Corne J, Chauhan AJ, et al. Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Respir J 2004;24:745-9.
47. Black PN, Blasi F, Jenkins CR, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001;164:536-41.
48. Miyashita N, Fukano H, Yoshida K, et al. Chlamydia pneumoniae infection in adult patients with persistent cough. J Med Microbiol 2003;52:265-9.
49. Kraft M, Casell GH, Pak J, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma. Effect of clarithromycin. Chest 2002;121:1782-8.